AAV.php.eb-husod1-sgrna
AAV.php.eb-husod1-sgrna has been studied in 1 paper since 2022: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Dec 1, 2022: “In vivo genome editing using novel AAV-PHP variants rescues motor function deficits and extends survival in a SOD1-ALS mouse model”.
1 paper studies it1 findingUpdated
See all 1 papers on AAV.php.eb-husod1-sgrna
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
- 1 lab in 1 country
- Funder: Biogen
- 1 of 1 finding with company ties
- Animals1
What did studies of AAV.php.eb-husod1-sgrna find?
1Studies of AAV.php.eb-husod1-sgrna measured one outcome, lifespan.
Lifespan
upin mice1
1 study
Lifespan
upin mice1
AAV.php.eb-husod1-sgrna extends lifespan in adult H11Cas9 SOD1G93A mice, immediately before symptom onset (>=170 days).
“also extended lifespan by at least 170 days”
Animalsin adult H11Cas9 SOD1G93A mice, immediately before symptom onsetintrathecal or intravenous injection
Gene therapy